Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaji Kumar

Showing results (411-420 of 434) with videos related to

Pageof 44
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2015
New cancers after autotransplantations for multiple myelomaAnuj Mahindra, Girindra Raval, Paulette Mehta, et al.
The Lancet. Oncology|December 3, 2014
International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaS Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, et al.
The Lancet. Oncology|June 5, 2019
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disordersJens Hillengass, Saad Usmani, S Vincent Rajkumar, et al.
Cancer|September 23, 2020
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United StatesTalha Badar, Parameswaran Hari, Omar Dávila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2020
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease ProgressionMark Bustoros, Romanos Sklavenitis-Pistofidis, Jihye Park, et al.
Leukemia|August 12, 2020
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trialsLuciano J Costa, Benjamin A Derman, Susan Bal, et al.
The Lancet. Oncology|August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myelomaShaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
Blood Cancer Discovery|December 9, 2025
Longitudinal profiling of tumor and immune compartments uncovers patterns of dysregulation and associations with response in multiple myelomaDenis J Ohlstrom, William C Pilcher, Marina E Michaud, et al.
American Journal of Hematology|December 10, 2019
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström MacroglobulinemiaSaurabh Zanwar, Jithma P Abeykoon, Eric Durot, et al.
Blood Advances|February 17, 2022
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphomaJoselle Cook, Kah-Whye Peng, Thomas E Witzig, et al.
Pageof 44

Showing results (411-420 of 434) with videos related to

Sort By:
Pageof 44
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2015
New cancers after autotransplantations for multiple myelomaAnuj Mahindra, Girindra Raval, Paulette Mehta, et al.
The Lancet. Oncology|December 3, 2014
International Myeloma Working Group updated criteria for the diagnosis of multiple myelomaS Vincent Rajkumar, Meletios A Dimopoulos, Antonio Palumbo, et al.
The Lancet. Oncology|June 5, 2019
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disordersJens Hillengass, Saad Usmani, S Vincent Rajkumar, et al.
Cancer|September 23, 2020
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United StatesTalha Badar, Parameswaran Hari, Omar Dávila, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2020
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease ProgressionMark Bustoros, Romanos Sklavenitis-Pistofidis, Jihye Park, et al.
Leukemia|August 12, 2020
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trialsLuciano J Costa, Benjamin A Derman, Susan Bal, et al.
The Lancet. Oncology|August 12, 2016
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myelomaShaji Kumar, Bruno Paiva, Kenneth C Anderson, et al.
Blood Cancer Discovery|December 9, 2025
Longitudinal profiling of tumor and immune compartments uncovers patterns of dysregulation and associations with response in multiple myelomaDenis J Ohlstrom, William C Pilcher, Marina E Michaud, et al.
American Journal of Hematology|December 10, 2019
Impact of MYD88<sup>L265P</sup> mutation status on histological transformation of Waldenström MacroglobulinemiaSaurabh Zanwar, Jithma P Abeykoon, Eric Durot, et al.
Blood Advances|February 17, 2022
Clinical activity of single-dose systemic oncolytic VSV virotherapy in patients with relapsed refractory T-cell lymphomaJoselle Cook, Kah-Whye Peng, Thomas E Witzig, et al.
Pageof 44